Clarify Mask

Natural health product licensed in Canada

Licence holder

CP Skin Health Group, Inc.

NPN or DIN-HM

80079683

Status

Active licence

Licence date

25 August 2017

Revision date

22 September 2026

Form

Crème

Route of administration

Topique

Application type

Non traditionnelle

Composition

Non-medicinal ingredients

Huile de Noix de Coco, Huile de pelures de Citrus aurantium dulcis (Oranger), Gluconate de sodium, Extrait de Candida saitoana hydrolysée, Filtrat de fermentation de racine de radis par la bactérie Leuconostoc, o-cymén-5-ol, Extrait d'écorce de Prunus Serotina (Merisier), Caprylyl glycol, Alcool, Alcool Cétylique, Acide citrique, Gomme de xanthane, Glycérine, Acétate de dl-alpha tocophéryle, Laureth-7, Diméthicone, Allantoïne, Extrait de fleur de Passiflora incarnata, EDTA de tétrasodium, Extrait d'hamamélis, Distéarate de glycol, Propylène glycol, Extrait de fruit de Prunus Avium (Cerisier sauvage), Isoparaffine en C13 à 14, Interpolymère de carbomère, Triglycéride caprylique/caprique, Parfum, Dioxyde de titane, Eau purifiée, Acide stéarique

Recommended doses in Canada

Uses authorised in Canada

For the treatment/management of acne. Helps treat acne pimples and allow skin to heal. Dries and helps clear up acne pimples and allow skin to heal. Reduces the number and/or severity of acne pimples and allow skin to heal. Penetrates pores to help control (reduce) acne pimples. Helps keep skin clear of new acne pimples. Helps prevent new acne pimples from forming.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

• Contre-indications

  Do not use on inflamed, irritated, reddened or broken skin. Not for use on individuals who are pregnant or breastfeeding, have diabetes, vitiligo, poor blood circulation, a herpetic breakout, open wounds, suspicious lesions, severely dry skin, currently suffer from any type of infection, are sensitive to aspirin/salicylic acid, have received recent chemotherapy or radiation therapy, used isotretinoin in the past 12 months or are taking photosensitizing medication.

• Effets indésirables connus

  Some people may experience a burning sensation, dermatitis, swelling, or blisters.

• Précautions et mises en garde

  For Professional Use Only. Use only as directed. Not For Retail Sale. For external use only. Keep out of reach of children. Patient should be explained the risks associated with this product prior to administration. Test product on a small area of the patient's skin, before applying to the whole area to be treated. If application causes severe discomfort or irritation, wash the area immediately with cold water and discontinue use. If irritation persists, consult a health care practitioner. If a severe reaction occurs (e.g. such as a chemical burn), seek immediate medical attention. Avoid contact with eyes and mucous membranes; if contact and irritation occur, rinse thoroughly with water. If swallowed, get medical help or contact a poison control centre immediately. This product may increase skin's sensitivity to the sun and particularly the possibility of sunburn. Please limit exposure to the sun and artificial UV light and apply a sunburn protectant while using this product and for a week afterwards. Avoid sport, swimming or the sauna for two days post treatment. Do not participate in laser or Intense Pulsed Light (IPL) facial treatments for 14 days post treatment. Using topical acne products or chemical peels at the same time or immediately following use of this product may increase dryness or irritation of the skin. Only one product should be used, unless directed by a health care practitioner. Use caution if the patient suffers from immunosuppression, is taking oral contraceptives or tetracycline, has a recent history of medical or cosmetic treatment/procedure (e.g. laser therapy, surgical procedures, cosmetic filler, microdermabrasion,etc.), smoking, herpes simplex, dermatitis, psoriasis, or any other inflammatory condition in the skin area to be treated (as these may have an impact on wound healing).

Source

Official Health Canada record, licence 80079683

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated 22 September 2026 (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

Has the product changed? Photograph the packaging.